Neogen Corporation

NEOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $397.9M $358.3M $321.3M $283.1M $247.4M $207.5M $184.0M $172.7M
Cost of Revenue $211.7M $189.6M $168.2M $143.4M $124.8M $98.0M $91.6M $84.9M
Gross Profit $186.3M $168.9M $153.1M $139.7M $122.6M $109.5M $92.4M $87.8M
Gross Margin 46.8% 47.1% 47.6% 49.3% 49.6% 52.8% 50.2% 50.8%
Operating Expenses
Research & Development $10.9M $10.4M $9.9M $9.6M $8.3M $7.8M $6.6M $6.8M
SG&A Expense $38.3M $34.2M $29.2M $25.2M $24.4M $20.2M $17.0M $15.1M
Operating Income $70.2M $64.9M $56.4M $53.1M $43.4M $40.7M $33.7M $35.8M
Operating Margin 17.6% 18.1% 17.6% 18.8% 17.5% 19.6% 18.3% 20.8%
Interest Expense
Pretax Income $73.5M $66.7M $55.5M $52.1M $43.0M $41.1M $33.8M $35.2M
Income Tax Expense $10.3M $22.7M $19.0M $18.5M $15.0M $14.1M $11.5M $12.4M
Net Income $63.1M $43.8M $36.6M $33.5M $28.2M $27.2M $22.5M $22.8M
Net Margin 15.9% 12.2% 11.4% 11.8% 11.4% 13.1% 12.2% 13.2%
EPS (Basic) $0.62 $0.44 $0.37 $0.46 $0.39 $0.38 $0.32 $0.50
EPS (Diluted) $0.61 $0.43 $0.36 $0.45 $0.38 $0.38 $0.31 $0.48
Shares Outstanding (Basic) 102.7M 101.1M 99.7M 73.9M 73.0M 71.5M 70.4M 46.0M
Shares Outstanding (Diluted) 104.3M 102.3M 101.0M 74.9M 74.5M 73.0M 72.1M 47.6M
Dividends Per Share
← Newer Page 2 of 3 Older →